25021-784 : Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC25021-784
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Fosaprepitant
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA204845
Rev. Date: 


NDC Package Codes:

  • 25021-784-10: 1 VIAL IN 1 CARTON (25021‑784‑10) > 5 ML IN 1 VIAL

Active Ingredients:

  • Fosaprepitant Dimeglumine

Dosage Strength:

  • 150 mg/5mL

Pharmaceutical Classes:

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]

Related Products:

Based on records with the same trade name.
  • 0338-0008 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0591-4385 Fosaprepitant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 16714-120 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16714-929 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 43598-859 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 60505-6105 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-972 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 67457-888 Fosaprepitant 115 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 67457-889 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 68001-421 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 69097-830 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Cipla USA Inc.
  • 69539-034 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Msn Laboratories Private Limited
  • 70625-300 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sungen Pharma, LLC
  • 70860-780 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
  • 71288-418 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 71839-104 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Be Pharmaceuticals Inc.
  • 72205-026 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Novadoz Pharmaceuticals LLC
  • 72606-569 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Celltrion USA, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-784 QR Code

< Prev: 25021-783Next: 25021-788 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 February 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA